455 related articles for article (PubMed ID: 33190086)
1. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.
Gluck WL; Callahan SP; Brevetta RA; Stenbit AE; Smith WM; Martin JC; Blenda AV; Arce S; Edenfield WJ
Respir Med; 2020 Dec; 175():106188. PubMed ID: 33190086
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange in the treatment of COVID-19 induced cytokine storm: the first Moroccan experience.
Bouayed MZ; Laaribi I; Benaini I; Yeznasni A; Berrajaa S; Oujidi Y; Bkiyar H; Abda N; Housni B
BMC Infect Dis; 2023 Nov; 23(1):829. PubMed ID: 38007416
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study.
Faqihi F; Alharthy A; Alodat M; Kutsogiannis DJ; Brindley PG; Karakitsos D
J Crit Care; 2020 Dec; 60():328-333. PubMed ID: 32763058
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic plasma exchange in a critically ill Covid-19 patient.
Altmayer V; Saheb S; Rohaut B; Marois C; Cao A; Gallo A; Le Guennec L; Weiss N; Demeret S
J Clin Apher; 2021 Feb; 36(1):179-182. PubMed ID: 32875601
[TBL] [Abstract][Full Text] [Related]
5. Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report.
Faqihi F; Alharthy A; Alshaya R; Papanikolaou J; Kutsogiannis DJ; Brindley PG; Karakitsos D
BMC Cardiovasc Disord; 2020 Aug; 20(1):389. PubMed ID: 32842957
[TBL] [Abstract][Full Text] [Related]
6. Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome.
Beraud M; Hashami SA; Lozano M; Bah A; Keith P
Transfus Apher Sci; 2022 Aug; 61(4):103433. PubMed ID: 35341691
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.
Kamran SM; Mirza ZE; Naseem A; Liaqat J; Fazal I; Alamgir W; Saeed F; Saleem S; Nisar S; Yousaf MA; Khan AZ; Hussain M; Azam R; Hussain M; Khan KA; Jamal Y; Iftikhar R
PLoS One; 2021; 16(1):e0244853. PubMed ID: 33411791
[TBL] [Abstract][Full Text] [Related]
9. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives.
Memish ZA; Faqihi F; Alharthy A; Alqahtani SA; Karakitsos D
Int J Antimicrob Agents; 2021 Feb; 57(2):106273. PubMed ID: 33370568
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Therapeutic Plasma Exchange in Severe Acute Respiratory Distress Syndrome in COVID-19 Patients from the Western Part of Romania.
Porosnicu TM; Gindac C; Popovici S; Marinescu A; Jipa D; Lazaroiu V; Sandesc D; Oancea C; Folescu R; Zamfir AS; Zamfir CL; Nussbaum LA; Sirbu IO
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556909
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial.
Faqihi F; Alharthy A; Abdulaziz S; Balhamar A; Alomari A; AlAseri Z; Tamim H; Alqahtani SA; Kutsogiannis DJ; Brindley PG; Karakitsos D; Memish ZA
Int J Antimicrob Agents; 2021 May; 57(5):106334. PubMed ID: 33838224
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
[TBL] [Abstract][Full Text] [Related]
15. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.
Knaup H; Stahl K; Schmidt BMW; Idowu TO; Busch M; Wiesner O; Welte T; Haller H; Kielstein JT; Hoeper MM; David S
Crit Care; 2018 Oct; 22(1):285. PubMed ID: 30373638
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange therapy support for critical COVID-19: A case report.
Hua T; Li M; Li X
Ther Apher Dial; 2021 Aug; 25(4):533-535. PubMed ID: 32940386
[No Abstract] [Full Text] [Related]
17. Therapeutic plasma exchange: A potential therapeutic modality for critically ill adults with severe acute respiratory syndrome coronavirus 2 infection.
Al-Hashami S; Khamis F; Al-Yahyay M; Al-Dowaiki S; Al-Mashaykhi L; Al-Khalili H; Chandwani J; Al-Salmi I; Al-Zakwani I
J Clin Apher; 2022 Dec; 37(6):563-572. PubMed ID: 36102158
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
[TBL] [Abstract][Full Text] [Related]
19. What Is the Role of Therapeutic Plasma Exchange as an Adjunctive Treatment in Severe COVID-19: A Systematic Review.
Krzych ŁJ; Putowski Z; Czok M; Hofman M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452349
[TBL] [Abstract][Full Text] [Related]
20. The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.
Wardhani SO; Fajar JK; Soegiarto G; Wulandari L; Maliga HA; Ilmawan M; Merysa R; Simamora AB; Aini Q; Noviantari K; Lestari AW; Harnila MY; Syafi'i I; Djianzonie JAC; Siagian N; Nining S; Hanim RZ; Wahyuni W; Aulia F; Juliansyah J; Mahmud R; Tamara F; Mahendra AI; Wowor AC; Baladraf F; Hadinata PH; Ikkeputri A; Nadya H; Kartini DA; Husnah M; Nainu F; Harapan H
F1000Res; 2021; 10():1280. PubMed ID: 35083038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
